Skip to content

Diagnostics of metal allergy associated with oral exposure

Diagnostics of metal allergy associated with oral exposure - Metal allergy diagnostics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30428
Enrollment
90
Registered
2007-07-23
Start date
2007-03-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tandheelkundige slijmvlies aandoeningen Metal allergy

Interventions

None listed

Sponsors

Universiteit van Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients (>18 year) where the anamnesis gives rise to a suspicion of a metal allergy based on an oral exposure and where intra-oral inspection showed one of the following symptoms: 1) not plaque related mucosa deviation (e.g. gingivitis, periodontitis), 2) Lichenoid reaction, 3) Lingua geographica, 4) Local erosion, 5) Edema, 6) Erythema.

Exclusion criteria

Exclusion criteria: Patients/volunteers where the anamnesis showed malignancies and/or systemic diseases, or other disorders that hinder the execution of in vivo or in vitro allergy testing. ;Patients/volunteers who are pregnant.;The use of drugs that interferes with in vivo and/or in vitro allergic diagnostic tests.;Patients not willing to undergo the general diagnostic examination as normally offered by the department of Dermato-Allergy (VUmc) or the department of Oral Diagnostics (ACTA).;Patients of the negative control group were not positive patch tested before and should not have a history of eczema.

Design outcomes

Primary

MeasureTime frame
Determination of correlation coefficients between test results of four selected tests mutually as well as in relation with the diagnostic image of metal allergiy linked to an oral exposure to dental alloys.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)